Recipharm cutting jobs in Sweden; Almac expands its manufacturing tech;

> Recipharm is planning to cut about 100 jobs in its native Stockholm, looking to reduce costs. More

> A New York private equity outfit acquired a 90% stake in Italian contract drugmaker Doppel Farmaceutici. Story

> Almac has expanded its drug development services to include new processing and encapsulation technology at its U.K. hub. Item